152 related articles for article (PubMed ID: 20028790)
21. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.
Tretter L; Patocs A; Chinopoulos C
Biochim Biophys Acta; 2016 Aug; 1857(8):1086-1101. PubMed ID: 26971832
[TBL] [Abstract][Full Text] [Related]
22. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
Evangelisti C; de Biase D; Kurelac I; Ceccarelli C; Prokisch H; Meitinger T; Caria P; Vanni R; Romeo G; Tallini G; Gasparre G; Bonora E
BMC Cancer; 2015 Mar; 15():157. PubMed ID: 25880213
[TBL] [Abstract][Full Text] [Related]
23. The Role of Succinate in Regulation of Immediate HIF-1α Expression in Hypoxia.
Lukyanova LD; Kirova YI; Germanova EL
Bull Exp Biol Med; 2018 Jan; 164(3):298-303. PubMed ID: 29308570
[TBL] [Abstract][Full Text] [Related]
24. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the TCA cycle: signaling to tumor formation.
Raimundo N; Baysal BE; Shadel GS
Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
[TBL] [Abstract][Full Text] [Related]
26. Oxygen concentration controls epigenetic effects in models of familial paraganglioma.
Her YF; Nelson-Holte M; Maher LJ
PLoS One; 2015; 10(5):e0127471. PubMed ID: 25985299
[TBL] [Abstract][Full Text] [Related]
27. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
29. Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1α expression.
Jones R; McDonald KE; Willson JA; Ghesquière B; Sammut D; Daniel E; Harris AJ; Lewis A; Thompson AA; Dickinson RS; Plant T; Murphy F; Sadiku P; Keevil BG; Carmeliet P; Whyte MK; Newell-Price J; Walmsley SR
Blood; 2016 May; 127(21):2641-4. PubMed ID: 27006389
[No Abstract] [Full Text] [Related]
30. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.
Pereira L; Soares P; Máximo V; Samuels DC
BMC Cancer; 2012 Feb; 12():53. PubMed ID: 22299657
[TBL] [Abstract][Full Text] [Related]
31. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation.
Schöpf B; Weissensteiner H; Schäfer G; Fazzini F; Charoentong P; Naschberger A; Rupp B; Fendt L; Bukur V; Giese I; Sorn P; Sant'Anna-Silva AC; Iglesias-Gonzalez J; Sahin U; Kronenberg F; Gnaiger E; Klocker H
Nat Commun; 2020 Mar; 11(1):1487. PubMed ID: 32198407
[TBL] [Abstract][Full Text] [Related]
32. NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma.
Lai RK; Xu IM; Chiu DK; Tse AP; Wei LL; Law CT; Lee D; Wong CM; Wong MP; Ng IO; Wong CC
Clin Cancer Res; 2016 Jun; 22(12):3105-17. PubMed ID: 26819450
[TBL] [Abstract][Full Text] [Related]
33. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
[TBL] [Abstract][Full Text] [Related]
34. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
Smith EH; Janknecht R; Maher LJ
Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
[TBL] [Abstract][Full Text] [Related]
35. Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells.
DeHaan C; Habibi-Nazhad B; Yan E; Salloum N; Parliament M; Allalunis-Turner J
Mol Cancer; 2004 Jul; 3():19. PubMed ID: 15248896
[TBL] [Abstract][Full Text] [Related]
36. Free radicals-mediated damage in transmitochondrial cells harboring the T14487C mutation in the ND6 gene of mtDNA.
Gonzalo R; Garcia-Arumi E; Llige D; Marti R; Solano A; Montoya J; Arenas J; Andreu AL
FEBS Lett; 2005 Dec; 579(30):6909-13. PubMed ID: 16337195
[TBL] [Abstract][Full Text] [Related]
37. Nonezymatic formation of succinate in mitochondria under oxidative stress.
Fedotcheva NI; Sokolov AP; Kondrashova MN
Free Radic Biol Med; 2006 Jul; 41(1):56-64. PubMed ID: 16781453
[TBL] [Abstract][Full Text] [Related]
38. 2-Oxoglutarate-dependent dioxygenases in cancer.
Losman JA; Koivunen P; Kaelin WG
Nat Rev Cancer; 2020 Dec; 20(12):710-726. PubMed ID: 33087883
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
Hollinshead KE; Tennant DA
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
[TBL] [Abstract][Full Text] [Related]
40. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation.
Bedogni B; Welford SM; Cassarino DS; Nickoloff BJ; Giaccia AJ; Powell MB
Cancer Cell; 2005 Dec; 8(6):443-54. PubMed ID: 16338658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]